RBC Capital Mkts initiated coverage on Applied Therapeutics with a new price target

3/26/24 7:58:04 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

RBC Capital Mkts initiated coverage of Applied Therapeutics with a rating of Outperform and set a new price target of $12.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$APLT

Date	Price Target	Rating	Analyst
12/23/2024		Outperform → Mkt Perform	William Blair
12/2/2024	$13.00 → $2.00	Buy → Neutral	UBS
11/29/2024	$12.00 → $4.00	Outperform → Sector Perform	RBC Capital Mkts
7/31/2024		Outperform	William Blair
3/26/2024	$12.00	Outperform	RBC Capital Mkts
2/22/2024	$12.00	Outperform	Leerink Partners
1/4/2022	$44.00 → $7.00	Overweight → Equal-Weight	Barclays
8/27/2021	$10.00	Neutral → Sell	Goldman Sachs